share_log

8-K/A: Current report (Amendment)

8-K/A: Current report (Amendment)

8-K/A:重大事件(修正)
美股SEC公告 ·  10/22 05:05

牛牛AI助理已提取核心訊息

Heart Test Laboratories, Inc., now known as HeartSciences Inc., has officially changed its corporate name following the filing of a Certificate of Amendment with the Secretary of State of Texas on October 11, 2024. This name change was previously approved by shareholders during the Annual Meeting on January 17, 2024. The company's common stock and public warrants are expected to commence trading under the new name on The Nasdaq Capital Market from October 23, 2024. Despite the name change, the ticker symbols (HSCS for common stock and HSCSW for warrants) and the CUSIP numbers for the company's securities will remain unchanged. Current stock certificates and public warrants will continue to be valid and do not require exchange. The name change is the sole alteration to the company's Amended and Restated Certificate of Formation, with no other changes reported.
Heart Test Laboratories, Inc., now known as HeartSciences Inc., has officially changed its corporate name following the filing of a Certificate of Amendment with the Secretary of State of Texas on October 11, 2024. This name change was previously approved by shareholders during the Annual Meeting on January 17, 2024. The company's common stock and public warrants are expected to commence trading under the new name on The Nasdaq Capital Market from October 23, 2024. Despite the name change, the ticker symbols (HSCS for common stock and HSCSW for warrants) and the CUSIP numbers for the company's securities will remain unchanged. Current stock certificates and public warrants will continue to be valid and do not require exchange. The name change is the sole alteration to the company's Amended and Restated Certificate of Formation, with no other changes reported.
Heart Test Laboratories, Inc., 現已更名爲HeartSciences Inc.,根據2024年10月11日向德克薩斯州國務卿提交的修正證書,其公司名稱正式更名。此名稱變更先前已在2024年1月17日年度股東大會上獲得批准。公司的普通股和公開認股權證有望自2024年10月23日開始在納斯達克資本市場上以新名稱進行交易。儘管更名,公司證券的股票代碼(普通股爲HSCS,認股權證爲HSCSW)和CUSIP編號將保持不變。目前的股票證書和公開認股權證將繼續有效,無需交換。公司修正和重設成立證書的唯一變更是名稱更改,未報告其他更改。
Heart Test Laboratories, Inc., 現已更名爲HeartSciences Inc.,根據2024年10月11日向德克薩斯州國務卿提交的修正證書,其公司名稱正式更名。此名稱變更先前已在2024年1月17日年度股東大會上獲得批准。公司的普通股和公開認股權證有望自2024年10月23日開始在納斯達克資本市場上以新名稱進行交易。儘管更名,公司證券的股票代碼(普通股爲HSCS,認股權證爲HSCSW)和CUSIP編號將保持不變。目前的股票證書和公開認股權證將繼續有效,無需交換。公司修正和重設成立證書的唯一變更是名稱更改,未報告其他更改。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。